Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients - ScienceDirect
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months - eClinicalMedicine
xmlinkhub
Antibody responses to SARS-CoV-2 in patients with COVID-19 | Nature Medicine
SARS-CoV-2 mRNA vaccine induced higher antibody affinity and IgG titers against variants of concern in post-partum vs non-post-partum women - eBioMedicine
Immunogenicity of adenovirus-vector vaccine targeting hepatitis B virus: non-clinical safety assessment in non-human primates | Virology Journal | Full Text
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
HIV-1 Specific Antibody Titers and Neutralization among Chronically Infected Patients on Long-Term Suppressive Antiretroviral Therapy (ART): A Cross-Sectional Study | PLOS ONE
IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients | BMC Microbiology | Full Text
COVID-19 Antibody & Antigen Titer Assay Kits | AMSBIO
What is an antibody titer?
Predicting SARS-CoV-2 antibody titers
Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India in: The American Journal of Tropical Medicine and Hygiene Volume 105 Issue 2 (2021)
Vaccines | Free Full-Text | Large-Scale Study of Antibody Titer Decay following BNT162b2 mRNA Vaccine or SARS-CoV-2 Infection
Comparative Neuromuscular Laboratory
Frontiers | High Titers of Low Affinity Antibodies in COVID-19 Patients Are Associated With Disease Severity
Low serum neutralizing anti-SARS-CoV-2 S antibody levels in mildly affected COVID-19 convalescent patients revealed by two different detection methods | Cellular & Molecular Immunology
JCI Insight - Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19
Antibody Titers | VCA Animal Hospital
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients - ScienceDirect
SARS-CoV-2 and the Antibody Response in COVID-19 Patients | COVID-19 Immune Response
High Antibody Titer against Apical Membrane Antigen-1 Is Required to Protect against Malaria in the Aotus Model | PLOS ONE
COVID-19 Antibody & Antigen Titer Assay Kits | AMSBIO
Neutralizing antibody serologic assay kits for SARS-CoV-2 and its variants : Get Quote, RFQ, Price or Buy
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | NEJM
